🇺🇸 FDA

Intelligence · Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs · EMA approved · by data quality · Page 19 of 39

  1. pemigatinib

    PEMAZYRE

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    L01EN02

  2. pentosan polysulfate sodium

    ELMIRON

    ORAL FDA: approved · EMA: approved

    G04BX15

  3. perflutren

    LUMINITY

    INTRAVENOUS FDA: approved · EMA: approved

    V08DA04

  4. pertuzumab

    PERJETA Hoffmann-La Roche

    SINGLE-USE FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FD02

  5. pirtobrutinib

    JAYPIRCA

    ORAL FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L01

  6. pitolisant

    OZAWADE

    FILM COATED FDA: approved · EMA: approved

    N07XX11

  7. prasterone

    INTRAROSA

    VAGINAL FDA: approved · EMA: approved

    G03XX01

  8. pretomanid

    DOVPRELA (PREVIOUSLY PRETOMANID FGK)

    ORAL FDA: approved · EMA: approved

    J04

  9. ramucirumab

    CYRAMZA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    L01FX06

  10. ranibizumab

    LUCENTIS Novartis Pharmaceuticals

    INJECTION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    S01LA04

  11. rasburicase

    FASTURTEC

    INTRAVENOUS FDA: approved · EMA: approved · PMDA: approved

    V03AF07

  12. regadenoson

    RAPISCAN

    INTRAVENOUS FDA: approved · EMA: approved

    C01EB21

  13. regorafenib

    STIVARGA

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    L01EX05

  14. relugolix

    ORGOVYX

    ORAL FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    H01CC54

  15. remdesivir

    VEKLURY

    INTRAVENOUS FDA: approved · EMA: approved · PMDA: approved

    J05AB16

  16. remibrutinib

    RHAPSIDO

    ORAL FDA: approved · EMA: approved

    L04AA60

  17. repotrectinib

    AUGTYRO

    ORAL FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    L01EX28

  18. ribociclib

    KISQALI Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01EF02

  19. rilpivirine

    EDURANT Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG05

  20. rilzabrutinib

    WAYRILZ

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    Not yet assigned

  21. rimegepant

    VYDURA

    ORAL FDA: approved · EMA: approved

    N02CD06

  22. ripretinib

    QINLOCK

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01

  23. risdiplam

    EVRYSDI Hoffmann-La Roche

    ORAL FDA: approved · EMA: approved · TGA: approved

    M09AX10

  24. rituximab

    RIXIMYO Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FA01

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.